Journals / Perinatal journal (Online) / 2022 / Cilt: 30 - Sayı: 1

Multifetal pregnancy reduction outcomes from triplets to singletons and twins

Pages
21–27
Publication Date
2022-10-19
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Multifetal pregnancy reduction of triplets to singletons is associated with better pregnancy outcomes such as birth at higher weeks of gestation and higher neonatal birth weight than MPR of triplets to twins.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To study the obstetric and neonatal outcomes of reduction to singleton and twin pregnancies by multifetal pregnancy reduction (MPR) in patients with triplet pregnancies.
📊
Key Findings & Data:Methods: The multifetal reduction was performed in 27 patients with triplet pregnancies.
💡
Conclusion & Impact:Multifetal pregnancy reduction of triplets to singletons is associated with better pregnancy outcomes such as birth at higher weeks of gestation and higher neonatal birth weight than MPR of triplets to twins.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: To study the obstetric and neonatal outcomes of reduction to singleton and twin pregnancies by multifetal pregnancy reduction (MPR) in patients with triplet pregnancies. Methods: The multifetal reduction was performed in 27 patients with triplet pregnancies. Fourteen patients were reduced to singleton pregnancies and 13 patients to twin pregnancies. Obstetric and neonatal outcomes were compared between the two groups. Results: The mean gestational age at the time of the procedure was 12.43±0.76 weeks in patients reduced to singleton pregnancies and 12.08±0.64 weeks in those reduced to twin pregnancies. The most common complications of the procedure were abdominal pain (21.4%) in women with singleton pregnancies and both the presence of abdominal pain and vaginal bleeding (30.8%) in women with twin pregnancies. Gestational age at birth (33.07±5.73 versus 35.78±6.14 weeks, p=0.009) and neonatal birth weight (1998.46±808.07 versus 2765±803.03 gram, p=0.003) was significantly higher in the group reduced to singleton pregnancies than in twin pregnancies. Conclusion: The MPR procedure is a good and acceptable option for patients with multiple pregnancies of three or more children. Multifetal pregnancy reduction of triplets to singletons is associated with better pregnancy outcomes such as birth at higher weeks of gestation and higher neonatal birth weight than MPR of triplets to twins.

🔖

Cite This Article

SEZER, S., ACAR, Z., ÖZDEMİR, İ., ÖZKÖSE, Z. G., TUNÇ, Ş., GÜNKAYA, O. S., OĞLAK, S. C. (2022). Multifetal pregnancy reduction outcomes from triplets to singletons and twins. Perinatal journal (Online), Cilt: 30 - Sayı: 1, 21–27. https://ajindex.com/articles/588307

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Haas J, Hourvitz A, Dor J, Yinon Y, Elizur S, Mazaki-Tovi S, et al. Pregnancy outcome of early multifetal pregnancy reduction: triplets to twins versus triplets to singletons. Reprod Biomed Online 2014;29:717–21. [PubMed] [CrossRef] 2. Cihangir Y›lanl›oglu N, Semiz A, Arisoy R, Kahraman S, Arslan Gürkan A. The outcome of the multifetal pregnancy reduction procedures in a single centre: a report of 202 completed cases. Eur J Obstet Gynecol Reprod Biol 2018;230:22–7. [PubMed] [CrossRef] 3. O¤lak SC, Sakar MN, Ege S, Özçelik Otçu SM, Obut M, Kahveci B, et al. Comparison of the efficacy of letrozole and gonadotropin combination versus gonadotropin alone in intrauterine insemination cycles in patients with unexplained infertility. Eastern J Med 2020;25:427–33. [CrossRef] 4. Sakar MN, Oglak SC. Letrozole is superior to clomiphene citrate in ovulation induction in patients with polycystic ovary syndrome. Pak J Med Sci 2020;36:1460–5. [PubMed] [CrossRef] 5. Kupka MS, Ferraretti AP, de Mouzon J, Erb K, D’Hooghe T, Castilla JA, et al; European IVF-Monitoring Consortium, for the European Society of Human Reproduction and Embryology. Assisted reproductive technology in Europe, 2010: results generated from European registers by ESHRE†. Hum Reprod 2014;29:2099–113. [PubMed] [CrossRef] 6. van de Mheen L, Everwijn SM, Haak MC, Manten GT, Zondervan HA, Knapen MF, et al. Outcome of multifetal pregnancy reduction in women with a dichorionic triamniotic triplet pregnancy to a singleton pregnancy: a retrospective nationwide cohort study. Fetal Diagn Ther 2016;40:94–9. [PubMed] [CrossRef] 7. Joseph KS, Marcoux S, Ohlsson A, Kramer MS, Allen AC, Liu S, et al; Fetal and Infant Health Study Group of the Canadian Perinatal Surveillance System. Preterm birth, stillbirth and infant mortality among triplet births in Canada, 1985–96. Paediatr Perinat Epidemiol 2002;16:141–8. [PubMed] [CrossRef] 8. Elster N. Less is more: the risks of multiple births. The Institute for Science, Law, and Technology Working Group on Reproductive Technology. Fertil Steril 2000;74:617–23. [PubMed] [CrossRef] 9. Wimalasundera RC. Selective reduction and termination of multiple pregnancies. Semin Fetal Neonatal Med 2010;15:327– 35. [PubMed] [CrossRef] 10. Papageorghiou AT, Avgidou K, Bakoulas V, Sebire NJ, Nicolaides KH. Risks of miscarriage and early preterm birth in trichorionic triplet pregnancies with embryo reduction versus expectant management: new data and systematic review. Hum Reprod 2006;21